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aminolevulinic acid (ALA) are clinically useful for cancer treat
ments. Cancer cells have been reported that 5aminolevulinic acid
is incorporated via peptide transporter 1, which is one of the
membrane transport proteins, and has been reported to be signif
icantly expressed in various gastrointestinal cancer cells such as
Caco2. However, the mechanism of this protein expression has
not been elucidated. Concentration of reactive oxygen species
(ROS) is higher in cancer cells in comparison with that of normal
cells. We have previously reported that ROS derived from mito
chondria is likely related to invasions and proliferations of cancer
cells. Since 5aminolevulinic acid is the most important precursor
of heme which is necessary protein for cellular proliferations,
mitochondrial ROS (mitROS) may be also related to peptide trans
porter 1 expressions. In this study, we used a rat gastric mucosal
cell line RGM1 and its cancerlike mutated cell line RGK1, and we
clarified the ALA uptake mechanism and its relations between
mitROS and peptide transporter 1 expression in RGK1. We also
used our selfestablished stable clone of cell which overexpresses
manganese superoxide dismutase, a mitROS scavenger. We
studied differences of the photodynamic therapy effects in these
cells after ALA administrations to clear the influence of mitROS.
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IntroductionPhotodynamic therapy (PDT) using 5-aminolevulinic acid
(ALA) is one of the promising treatments for malignant
tumor because of its selectivity, low toxicity, rapid effect, and
rapid clearance from the body.(1) In traditional PDT, hemato-
porphyrin derivatives (HpDs) have been used.(2) These photo-
sensitizers show preferential tumor localization and light-
activated tumor destruction via photosensitization.(3) However,
these have harmful effects such as cutaneous photosensitivity.(4)
ALA is a precursor of protoporphyrinIX (PpIX), which enzymati-
cally converted ALA to PpIX in heme synthetic pathway.(5) In
many tumor cells such as gastric cancer cell and glioblastoma, an
excess of the exogenous pro-drug ALA results in the accumulation
of PpIX.(6,7) PpIX shows a phototoxic property through producing
singlet oxygen by exposing light at appropriate wavelength.(8–10)
On the other hand, ALA can avoid unexpected phototoxic pro-
perty of PDT using a photosensitizer because ALA accumulates in
tumor tissue selectively and shows a phototoxic property only when
it converted to PpIX.(11) ALA-induced PDT has been successfully
applied in various medical fields including gastroenterology,
urology and dermatology.(12,13) ALA has also been used as fluores-
cence marker for photodiagnosis of neoplasms.(12–14)
Several studies support to elucidate uptake-mechanism of
ALA.(15,16) Two peptide transporters are reported to be coincided
with the uptake; peptide transporter 1 (PEPT1) and peptide trans-
porter 2 (PEPT2). PEPT1 and PEPT2 are mainly expressed in the
small intestinal brush border membrane and luminal membrane
of renal proximal tubes, respectively. PEPT1 and PEPT2 mediate
the cellular uptake of dipeptides and tripeptides in a variety of
tissues.(17) However, the relations between ALA and these trans-
porter expressions are not clarified.
Reactive oxygen species (ROS) are generated through cellular
metabolism and played important roles in signaling pathways for
inducing growth factors such as platelet-derived growth factor
(PDGF) and epidermal growth factor (EGF).(18) In cancer cells,
ROS such as superoxide radical and hydroxyl radical are known to
enhance the growth, invasion and metastasis directly and/or indi-
rectly.(19,20) Generally, cancer cells produce more ROS than normal
cells(21) because of mitochondrial dysfunction, especially complex
I and III of electron transport chain.(22) We also reported that the
relation between mitochondrial ROS (mitROS) and a tumor inva-
sion using rat gastric mucosal cells, RGM1,(23) its chemically
oncogenic cancer-like cells, RGK1(24) and manganese superoxide
dismutase (MnSOD)-expressed RGK cells, RGK-MnSOD.(25)
MnSOD is located in mitochondria and scavenges mitROS specif-
ically.(26) ROS affects the expression of PEPT1,(27) however, the
relation between uptake of ALA and mitROS has not clearly
demonstrated.
In this study, we have clarified the relation between the uptake
of ALA through PEPT1 and mitROS using RGM1, RGK1 and
RGK-MnSOD. We mainly targeted not PEPT2 but PEPT1
because the expression amount of PEPT1 is larger in gastrointes-
tinal tract such as intestine, and PEPT2 is mainly expressed in
brain and kidney.(28) We investigated the expression of PEPT1, the
uptake of ALA using RI-labeling technique, and the amount of
synthesized porphyrin after exposing ALA and its PDT effect,
using RGM1, RGK1 and RGK-MnSOD cells to elucidate the
relation between the expression of PEPT1 and ALA-induced PDT
effect.
Materials and Methods
Materials. Radioisotope of [4-14C]-ALA hydrochloride
(American Radiolabeled Chemicals Inc., St. Louis, MO), 5-ALA
hydrochloride (Cosmo Bio Co., Ltd., Tokyo, Japan), Cell
Counting Kit-8 (DOJINDO, Tokyo, Japan), Pico-Fluor 40
(PerkinElmer Japan Co., Ltd., Kanagawa, Japan), Trizma® base
(Sigma-Aldrich Japan K.K., Tokyo, Japan), NaCl (Wako Pure
Chem. Ind. Ltd., Osaka, Japan), Triton X-100 (Sigma-Aldrich
P
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Japan K.K.), sodium dodecyl sulfate (SDS) (Wako), deoxycholic
acid (Wako), hydrochloric acid (Wako), NuPAGE® Novex® 12%
Bis-Tris gels (Life Technologies Japan Ltd., Tokyo, Japan), PVDF
Blocking Reagent for Can Get Signal® (TOYOBO CO., LTD.,
Osaka, Japan), Tris Buffered Saline with Tween® 20 (TBST-10X,
Cell Signaling Technology Japan, K.K., Tokyo, Japan), PEPT1
antibody (Abcam plc., Cambridge, U.K.), Can Get Signal®
Immunoreaction Enhancer Solution 1 (TOYOBO) horseradish
peroxidase (HRP) linked anti-rabbit IgG antibody (Cell Signaling
Technology Japan, K.K.), Lumina forte western HRP substrate
(Millipore Co., Billerica, MA), anti-β-actin (Cell Signaling),
and Can Get Signal® Immunoreaction Enhancer Solution 2
(TOYOBO) were purchased and used without further purification
or modification.
Cell culture. RGM1 and RGK1 were cultured in DMEM/F12
with L-glutamine (Life Technologies Japan Ltd.) and DMEM/F12
without L-glutamine (Sigma-Aldrich Japan K.K.), respectively.
These culture media contained 10% of inactivated fatal bovine
serum (FBS) (Biowest LLC, Kansas City, MO) and 1% of peni-
cillin/streptomycin (Life Technologies). All cells were cultured in
5% CO2 cell culture incubator at 37°C.
Cellular uptake of ALA. Cellular uptake of ALA was exam-
ined by use of radio isotope-labeled ALA ([4-14C]-ALA hydro-
chloride: RI-ALA). Cells were cultured on 6-well plate at 1 × 105
cells/well and incubated for overnight. The medium was
exchanged to flesh one which contained 0.03 mM of RI-ALA and
incubated at 37°C for 0.5, 1, 3 and 6 h. After incubation, cells were
washed by PBS, detached by trypsin/EDTA and collected to vials
containing liquid scintillation fluid (Pico-Fluor 40). Radiation
dose of the samples was determined in a liquid scintillation
counter (LSC-7200, Hitachi Aloka Medical, Ltd., Japan).
Porphyrin accumulation in cells. Synthesized porphyrin in
cells was measured as follows; Cells were incubated for overnight
on 6-well plate at 5 × 105 cells/well. The medium was exchanged
to flesh one which contained 1 mM of 5-ALA hydrochloride and
incubated for 0.5, 1, 3 and 6 h. After incubation, cells were dis-
solved with 100 μl of RIPA buffer which composed with 25 mM
of Tris-HCl solution (pH 7.6), 150 mM of NaCl, 1%(v/v) of Triton
X-100, 0.1%(w/v) of sodium dodecyl sulfate (SDS) and 0.2%(w/
v) of deoxycholic acid. The cell homogenates were transferred to
96-well plate and then the fluorescence intensity of porphyrin was
measured by a Varioskan micro plate reader (Thermo Fisher
Scientific K.K., Kanagawa, Japan). The measurement wavelength
of excitation and emission were 409 nm and 634 nm, respectively.
Western blotting analysis of PEPT1. Western blotting
analysis was performed according to previous reports.(25,29,30)
Briefly, 15 μl of cell lysed solution (10 μg) from each cells were
prepared with NuPAGE LDS Sample buffer containing Sample
Reducing Agent (Invitrogen Japan K.K., Tokyo, Japan) and boiled
at 70°C for 10 min. For SDS-polyaclylamidegel electrophoresis
(SDS-PAGE), the cell lysed solutions were added into well of
NuPAGE® Novex® 12% Bis-Tris gels. Since the gel was electro-
phoresed at 200 V for 30 min, protein were transferred onto a
polyvinylidene difluoride (PVDF) membrane (EMD Millipore
Co., Billerica, MA) by electrophoresis at 4.0 A·cm−2 for 10 min.
The sandwich immune assay was performed by SNAP i.d.
(Millipore), which is a suction type immune reaction system and
antibody reaction steps could be performed for about 30 min.
After 15 ml of PVDF Blocking Reagent for Can Get Signal® was
exposed to membrane and aspirated, an anti-rabbit PEPT1 anti-
body (1:500), which was primary antibody in this experiment, was
added in Can Get Signal® Immunoreaction Enhancer Solution 1
and the solution was exposed to the membrane for 10 min. After
the primary antibody solution was aspirated, the membrane was
washed three times by 15 mL of 1 X TBST. HRP-linked anti-
rabbit IgG antibody was cultured in Can Get Signal® Immunoreac-
tion Enhancer Solution 2. The solution was exposed to the mem-
brane for 10 min. The membrane was immersed in Lumina forte
western HRP substrate (Millipore), luminescence was then
observed by LAS4000 (GE Health Care Japan, Tokyo, Japan). β-
actin was detected with anti-β-actin as a control for protein
loading.
Cell viability test after PDT. Cell viability test after PDT
was performed according to manufacturer’s protocol and previous
report.(31) Briefly, cells were incubated for overnight on 96-well
plate at 2 × 104 cells/well. The medium was exchanged to flesh
one which contained 1 mM of ALA and incubated for 0.5, 1, 3 and
6 h. After incubation, cells were washed by PBS twice and the
flesh medium without phenol red (Life Technologies) was added.
Subsequently, cells were irradiated to the excimer dye laser light
(630 nm, 1 J/cm2) for PDT by use of PDT EDL-1 (Hamamatsu
Photonics K.K., Hamamatsu, Japan). After photo-irradiation, cells
were incubated for 24 h. The medium was replaced to flesh one
containing 10% of Cell Counting Kit-8 and then further incubated
for 2 h. The absorbance of 450 nm was measured by the Varioskan
micro plate reader (Thermo Fisher Scientific K.K.).
Static analysis. Static significant value (p value) was calcu-
lated using SPSS software (IBM Corp., Armonk, NY) followed
by Turkey HSD.
Results
Cancer cellular specific uptake of ALA. In order to investi-
gate cellular uptake manner of ALA in association with mitROS,
cellular uptake of ALA was examined using RI-labeled ALA
(14C-ALA). Fig. 1 showed cancer cell specific uptake of ALA:
14C-ALA was particularly incorporated into the cancerous cell in a
time-dependent manner to show significant difference between the
normal cells after 3 h. In RGK-MnSOD cells, the amount of this
cancer specific ALA accumulation was significantly less than
RGK1 cells after 3 h. After 1 mM ALA exposure, the cells
expressed a slight cytotoxicity (data not shown), and the differ-
ences of cell viability among the cells were negligible. Therefore,
1 mM ALA was used for the following experiments.
Measurement of porphyrin fluorescence synthesized in
cells. To study the influence of mitROS to the porphyrin
synthetic efficiency from ALA, fluorescence intensity of por-
phyrin synthesized in each cell after ALA exposure was measured.
Fig. 2 showed the relation between an exposed time of ALA and
the 634 ± 6 nm intensity of fluorescence which was indicative of
Fig. 1. Cellular uptake of 14Clabeled ALA. Cells were exposed to
culture medium containing 0.03 mM of RIlabeled ALA. This figure
showed cancer cells specific uptake of ALA and its significant decrease
in MnSOD expressed cancer cells. n = 4, Error bar; SD. *p<0.001.
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biosynthesized porphyrins. Porphyrin’s fluorescence intensity in
cancer cells was greater than that of normal cells. Furthermore,
this fluorescent intensity of synthesized porphyrin in RGK-
MnSOD cells was lower than in the cancer cells. This result
showed the same tendency as the result of cellular uptake of ALA
(Fig. 1). This phenomenon is thus likely to be caused by incorpo-
rated ALA.
PEPT1 protein expression in cells. Due to elucidation of
the uptake mechanism of ALA, PEPT1 expressions in RGM1,
RGK1 and RGK-MnSOD cells were determined by western
blotting analysis. Fig. 3a showed the protein expression of PEPT1
and β-actin. Fig. 3b showed the expression ratio of PEPT1 and β-
actin. PEPT1 expression level in RGK1 was greater than that in
RGM1. Additionally, the protein expression was decreased in
RGK-MnSOD suggesting that mitROS was likely to upregulate
the expression of PEPT1 using these cells.
Cancer cell specific death by PDT. Photodynamic therapies
were performed after the ALA treatments and their efficacies were
studied by WST assay. Fig. 4 showed that the longer time of ALA
incubation caused the lower cell viability in RGK cells besides
RGM1 and RGK-MnSOD cells did not. These results suggested
that the uptake of ALA and porphyrin accumulation is controlled
by the mitROS levels, thus the mitROS levels regulated ALA-
PDT effect.
Discussion
In this study, we demonstrated for the first time that mitROS
plays an important role for both cellular ALA uptake and por-
phyrin accumulation in gastric epithelial cells. We examined
cellular ALA uptake for following three cell lines; normal gastric
epithelial cells RGM1, its mutated cancer-like cells with chemical
carcinogen RGK1 and MnSOD overexpressing RGK1 (RGK-
MnSOD). The amounts of incorporated ALA in cancer cells
were about five times greater than that in normal cells after 6 h
incubation. Furthermore, the amounts were decreased by MnSOD
overexpression (Fig. 1). These results indicated that mitROS was
most likely to accelerate ALA uptake.
In this study, the amount of porphyrin accumulation in cancer
cells was significantly higher than that of normal cells 6 h after
Fig. 2. Porphyrin accumulation in cells after 1 mM of ALA exposure.
Cells were incubated in 1 mM of ALAcontaning medium for each
hour and dissolved in RIPA buffer. Then fluorescence of porphyrin was
measured by micro platereader. Cancer cells produced much greater
amounts of porphyrin than normal cells, and a little greater than
MnSOD expressed cells. n = 4, Error bar; SD. *p<0.001.
Fig. 3. Western blot analysis of PEPT1 protein expression in each cell.
PEPT1 protein bands of each cell (a), and PEPT1 expression levels in each
cell were represented by means of graph (b). PEPT1 was expressed
greater in cancer cells and suppressed in normal and MnSOD expressed
cells. These results were relative to uptake of ALA.
Fig. 4. PDT effect was examined after exposing ALA. Cell viability
was evaluated after ALA exposure and photoirradiation. Cancer cells
specific death was observed and the death was suppressed by expressing
MnSOD. n = 4, Error bar; SD. *p<0.05, **p<0.01.
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ALA treatment. MnSOD overexpression significantly restrained
this cancer specific porphyrin accumulation (Fig. 2). We have
previously reported that cancer specific high concentration of
nitric oxide (NO) involved the cancer specific porphyrin accumu-
lation. A key enzyme in heme biosynthesis is ferrochelatase. An
active site of this enzyme is 2Fe-2S cluster which can be inacti-
vated by NO to create dinitrosyl iron complexes (DNICs) irrevers-
ibly. Thus the conversion from protoporphyrin into heme can be
inhibited to decrease porphyrin accumulation in cancer cells
because inducible NO synthase used to be upregulated in cancer
cells. Intracellular NO can react with superoxide anion to create
peroxynitrite as following chemical formula: NO + O2− →
ONOO−.(30) Therefore NO concentration can increase when super-
oxide anion is scavenged. Since peroxynitrite cannot react with
2Fe-2S cluster, NO concentration increase after superoxide anion
suppression probably accelerates porphyrins accumulation. How-
ever, superoxide anion suppression by MnSOD overexpression
decreases the amount of intracellular porphyrins in this study.
Therefore, not only the inactivation of ferrochelatase, but also
ALA incorporation is likely to be important for the cancer specific
porphyrin accumulation.
ALA itself has been reported to involve mitochondrial ROS
production. Onuki et al.(33) reported that exogenous ALA treat-
ment causes cellular ROS production to injured rat liver mitochon-
dria which derived generation of mitROS secondly. Since ROS
after mitochondrial damage with functional inhibition of electron
transport system used to be superoxide anion, the kind of ROS
secondly involved by ALA treatment is also likely to be it. Since
Fernando et al.(34) reported that ALA induced ROS production in
rat cerebellum tissue and it was suppressed by exogenous SOD
which scavenges superoxide anion, the primary generated ROS
after ALA treatment were suggested to be superoxide anion.
Taken together, ALA treatment is likely to accelerate ALA uptake
via an induction of intracellular high ROS concentration after
mitochondrial injury. In our study, overexpression of MnSOD
decreased cancer cellular specific ALA uptake. This phenomenon
seems to be involved not only by cancer specific high ROS
concentration, but also by ALA-derived ROS. We propose that
the amount of ALA uptake is able to maintain by the regulation of
MnSOD expression.
ALA is transported into cells via PEPT1.(35) Ziegler et al.(36)
reported that colonic mucosal PEPT1 expression was upregulated
in patients with inflammatory bowel disease (IBD). Additionally,
ROS concentration in the intestinal mucosa of IBD patients is
higher in comparison with normal mucosa.(37) This IBD mucosal
specific ROS has been reported to be derived from mitochon-
dria.(38) Since cancer cellular ROS concentration used to be higher
as described above, PEPT1 expression is probably higher in com-
parison with normal cells. In fact, our result clearly demonstrated
that cancer cells particularly overexpressed PEPT1 protein, and
MnSOD overexpression significantly decreased it (Fig. 3). These
results indicated the amounts of ALA uptake in gastric cells were
dependent on the amounts of PEPT1-expression which was regu-
lated by mitROS.
We also examined influence of mitROS on ALA-PDT effect
with MnSOD overexpressing cells. Kim et al.(39) reported ALA-
PDT induced cell death in various cancer cells such as squamous
cell carcinoma, esophageal carcinoma and glioma, effectively.
Since generation of singlet oxygen, which was a key ROS to
derive cancer cellular apoptosis, was dependent on the amount
of porphyrins, the uptake of ALA, a precursor of porphyrins, was
very important factor to decide the PDT effect. In this study,
suppression of mitROS with MnSOD overexpression significantly
decreased the effect of PDT. At that time, the amounts of fol-
lowing three important factors also decreased significantly;
PEPT1 expression, ALA uptake and intracellular porphyrins
accumulation (Fig. 4). Therefore, we concluded that mitROS
regulated the effect of PDT via the amount control of PEPT1 to
derive ALA incorporation. We proposed that the effect of ALA-
PDT could be increased by the regulation of mitROS.
In conclusion, we have demonstrated that PEPT1 is most likely
to be a membrane transporter for cancer specific ALA incorpora-
tion. Cancer specific high mitROS concentration plays an impor-
tant role for this phenomenon. Now we are undergoing to establish
a therapeutic method to involve cancer specific acceleration of
mitROS for more effective PDT.
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